Antagonizing IL-6 receptor restores pancreatic tissue resident NK cells activation and ameliorates pancreatic injury in the mouse model of MASH
Background and aimMetabolic-associated steatohepatitis (MASH) and pancreatic inflammation are key complications of obesity-related metabolic syndrome. Elevated IL-6; a proinflammatory cytokine, contributes to liver steatosis and pancreatic β-islet cells dysfunction. This study explores pancreatic ti...
Saved in:
| Main Authors: | Johnny Amer, Diana Abu Arra, Ahmad Salhab, Faris Kayed, Muneer Maali, Raghad Shweiki, Mustafa Ghanim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1611637/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insulin Modulates NK Cell Activity in Liver Fibrosis MASH Patients via the STING Pathway
by: Johnny Amer, et al.
Published: (2025-06-01) -
Establishment and validation of an immune-related nomogram for the prognosis of pancreatic adenocarcinoma
by: Kan Wang, et al.
Published: (2025-04-01) -
Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer
by: Huocong Huang, et al.
Published: (2019-10-01) -
Chimeric Antigen Receptor (CAR)-NK92 cells effective against glioblastoma, breast- and pancreatic cancer in vitro and in a murine xenograft model of ovarian cancer
by: Abdelhadi Boulifa, et al.
Published: (2025-07-01) -
Correlation Between Interleukin IL-6/IL-6 Receptor Polymorphisms (<i>IL6</i>–174C>G and <i>IL6R</i> 1073A>C) and RAS/BRAF Mutations in Patients with Colorectal Cancer
by: Ekaterina Smagina, et al.
Published: (2025-02-01)